Integra Lifesciences Holdings Corp (NASDAQ: IART) kicked off on Tuesday, down -5.26% from the previous trading day, before settling in for the closing price of $20.34. Over the past 52 weeks, IART has traded in a range of $20.10-$45.42.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 1.17% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -20.99%. With a float of $65.06 million, this company’s outstanding shares have now reached $78.17 million.
In an organization with 5329 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 56.92%, operating margin of 7.77%, and the pretax margin is 1.73%.
Integra Lifesciences Holdings Corp (IART) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Integra Lifesciences Holdings Corp is 16.15%, while institutional ownership is 90.63%. The most recent insider transaction that took place on Aug 19 ’24, was worth 25,701. In this transaction SVP, Fin & Princ Acct Officer of this company sold 1,191 shares at a rate of $21.58, taking the stock ownership to the 36,088 shares. Before that another transaction happened on May 23 ’24, when Company’s Exec. Chairman of the Board bought 52,641 for $28.49, making the entire transaction worth $1,499,979. This insider now owns 487,922 shares in total.
Integra Lifesciences Holdings Corp (IART) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported 0.76 earnings per share (EPS), lower than consensus estimate (set at 0.78) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.87 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -20.99% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.30% during the next five years compared to 3.10% growth over the previous five years of trading.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Trading Performance Indicators
Take a look at Integra Lifesciences Holdings Corp’s (IART) current performance indicators. Last quarter, stock had a quick ratio of 2.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.95. Likewise, its price to free cash flow for the trailing twelve months is 25.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.30, a number that is poised to hit 0.39 in the next quarter and is forecasted to reach 2.51 in one year’s time.
Technical Analysis of Integra Lifesciences Holdings Corp (IART)
Let’s dig in a bit further. During the last 5-days, its volume was 0.58 million. That was inferior than the volume of 1.13 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 14.85%. Additionally, its Average True Range was 0.91.
During the past 100 days, Integra Lifesciences Holdings Corp’s (IART) raw stochastic average was set at 1.50%, which indicates a significant decrease from 7.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.60% in the past 14 days, which was lower than the 61.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $25.81, while its 200-day Moving Average is $33.67. However, in the short run, Integra Lifesciences Holdings Corp’s stock first resistance to watch stands at $20.00. Second resistance stands at $20.74. The third major resistance level sits at $21.22. If the price goes on to break the first support level at $18.79, it is likely to go to the next support level at $18.31. Assuming the price breaks the second support level, the third support level stands at $17.57.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Key Stats
The company with the Market Capitalisation of 1.49 billion has total of 78,800K Shares Outstanding. Its annual sales at the moment are 1,542 M in contrast with the sum of 67,740 K annual income. Company’s last quarter sales were recorded 418,180 K and last quarter income was -12,400 K.
